Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Van Dyk

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Medical and Pediatric Oncology|January 1, 1975
A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanomaJ J Van Dyk, G Falkson
Cancer Chemotherapy and Pharmacology|January 1, 1982
Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatmentG Falkson, J J Van Dyk, R Stapelberg, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 17, 1976
Adriamycin in the treatment of cancerJ J van Dyk, A M van der Merwe, H C Falkson, et al.
Cancer|April 1, 1975
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213G Falkson, J J van Dyk, E B van Eden, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medical and Pediatric Oncology|January 1, 1975
A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanomaJ J Van Dyk, G Falkson
Cancer Chemotherapy and Pharmacology|January 1, 1982
Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatmentG Falkson, J J Van Dyk, R Stapelberg, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 17, 1976
Adriamycin in the treatment of cancerJ J van Dyk, A M van der Merwe, H C Falkson, et al.
Cancer|April 1, 1975
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213G Falkson, J J van Dyk, E B van Eden, et al.
Pageof 1